Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



European Patent For Arecor’s Proprietary Technology Enabling Highly Concentrated Biotherapeutics

Arecor Ltd, the UK-based leading formulation technology company, focussed on developing superior biopharmaceuticals via the innovative reformulation of proteins and peptides, is pleased to announce the European Patent Office (“EPO”) has issued “Notice of Intention to Grant” for Arecor’s patent application protecting the Company’s proprietary technology used in the development of stable, low-viscosity formulations of highly concentrated protein therapeutics, including monoclonal antibodies such as trastuzumab or ustekinumab or fusion proteins such as abatacept. 

Read the rest of entry »

Examination of Non-sterile Products: Application Note Published in European Pharmaceutical Review

Wickham Laboratories is pleased to announce their most recent Application Note, “Examination of Non-sterile Products: Tests for Specified Microorganisms” which is featured in the December 2017 issue of European Pharmaceutical Review.

Read the rest of entry »

Immunocore Strengthens its Board with Appointments of Laura Wade-Gery and Kristine Peterson as Non-Executive Directors

Immunocore Limited, the world’s leading TCR company focused on delivering first-in-class biologics that transform lives, today announces the appointment of Laura Wade-Gery and Kristine Peterson as Non-Executive Directors.

Read the rest of entry »

Arecor and JDRF Announce Successful Pre-clinical Development of Stable Rapid-Acting, Ultra-Concentrated Insulin for the significantly enhanced treatement of Type 1 Diabetes

“Arecor’s proprietary insulin product to progress into human clinical trials in 2018”

Read the rest of entry »

Oxford Immunotec to Present at the 36th Annual J.P. Morgan Healthcare Conference

Oxford Immunotec Global PLC, a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, will present at the 36th Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2018, at 11:00 a.m. PST (2:00 p.m. EST). The conference will be held at the Westin St. Francis Hotel in San Francisco.

Read the rest of entry »

Wessex Academic Health Science Network and Wessex Clinical Research Network launch their Technology Support Programme (Round 1)

Wessex Clinical Research Network (CRN) and Wessex Academic Health Science Network (AHSN) have teamed up to support commercial innovators gather crucial evidence on their products.  Their new Technology Support Programme (TSP) will help companies to access the NHS’s research infrastructure to obtain high quality evidence on the economic and health gains their products can bring.

Read the rest of entry »

Highest Stability Recombinant Wnt3a for Organoid Culture

AMSBIO has introduced recombinant Wnt3a with a new Wnt stabilizer that significantly extends the activity of this protein in serum-free medium from a half-life of just 2 hours to around 30 hours.

Read the rest of entry »

Boehringer Ingelheim signs Evox, Roche deals

A second deal between Germany’s Boehringer Ingelheim and a UK firm has been announced this week, this time with Oxford-based Evox Therapeutics for a collaboration focused on exosome-mediated drug delivery.

Read the rest of entry »

Isansys Lifecare partners with myHealth Sentinel

Isansys Lifecare, a global health technology company, is delighted to announce its partnership with myHealth Sentinel (mHS) to offer its wireless, wearable, continuous patient data capture and analysis platform in Singapore.

Read the rest of entry »

Isansys Lifecare partners with myHealth Sentinel

Oxford, UK: Isansys Lifecare, a global health technology company, is delighted to announce its partnership with myHealth Sentinel (mHS) to offer its wireless, wearable, continuous patient data capture and analysis platform in Singapore.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.